Normalized pooled gene expression data from multiple studies

{"longTitle":"Breast Cell Line Exon Expression (Gray Lab)","cohort":"Breast Cancer Cell Lines (Heiser 2012)","url":"http://www.ncbi.nlm.nih.gov/pubmed/22003129","dataSubType":"gene expression","citation":"Proc Natl Acad Sci U S A. 2012 Feb 21;109(8):2724-9.","label":"Breast Cell Line Gene Expression","articletitle":"Subtype and pathway specific responses to anticancer compounds in breast cancer","tags":["cell lines","cancer"],"anatomical_origin":["Breast"],"name":"grayBreastCellLines_public/grayBreastCellLineExon_genomicMatrix","dataproducer":"Heiser LM, Sadanandam A, Kuo WL, Benz SC, Goldstein TC et. al.","sample_type":["cell line"],"type":"genomicMatrix","wrangler":"Kyle Ellrott","version":"2012-06-16","gdata_tags":["transcription","mRNA"],"primary_disease":"breast cancer","colnormalization":true,"pmid":22003129,"description":"The dataset shows the gene-level gene expression profile of a collection of breast cancer cell lines from the Gray Lab. GI50 to 77 therapeutic compounds as well as ER, HER2 and other phenotypic information is shown as the clinical data."}

Breast Cell Line Exon Expression (Gray Lab)

{"longTitle":"Breast Cell Line Copy Number Segmented (Gray Lab)","cohort":"Breast Cancer Cell Lines (Heiser 2012)","url":"http://www.ncbi.nlm.nih.gov/pubmed/22003129","dataSubType":"copy number","citation":"Proc Natl Acad Sci U S A. 2012 Feb 21;109(8):2724-9.","label":"Breast Cell Line Copy Number","articletitle":"Subtype and pathway specific responses to anticancer compounds in breast cancer","tags":["cancer"],"name":"grayBreastCellLines_public/grayBreastCellLineSNPSeg_genomicSegment","dataproducer":"Heiser LM, Sadanandam A, Kuo WL, Benz SC, Goldstein TC et. al.","wrangling_procedure":"CBS Segmented copy number SNP6 dataset is provided by the authors.","assembly":"hg18","type":"genomicSegment","wrangler":"Kyle Ellrott","version":"2012-02-24","pmid":22003129,"description":"The dataset shows the segmented copy number profile of a collection of breast cancer cell lines from the Gray Lab. GI50 to 77 therapeutic compounds as well as ER, HER2 and other phenotypic information is shown as the clinical data.\n\nGenomic copy number was assessed using the Affymetrix Genome-Wide Human SNP Array 6.0 analysis platform. Arrays were analyzed using aroma.affymetrix(http://aroma-project.org), data were normalized and DNA copy number ratios at each locus were estimated relative to a set of 20 normal sample arrays.  Data were segmented using circular binary segmentation (CBS) from the bioconductor package DNAcopy. Raw SNP6 data is available in the European Genotype Archive (EGAS00000000059), and is published in conjunction with Neve et al Cancer Cell 2006 (PMID:17157791)."}